hyaluronoglucosaminidase has been researched along with Diabetes Mellitus, Type 2 in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Cielecka-Piontek, J; Sip, A; Sip, S; Szulc, P | 1 |
| Dai, A; Dillmann, WH; Lai, N; Makino, A; Scott, BT; Si, R; Tsuji-Hosokawa, A; Wang, J; Watanabe, M; Willson, C; Yuan, JX; Zhang, Q | 1 |
| Arumugam, TV; Jo, DG; Lai, MKP; Park, J | 1 |
| Issad, T; Larger, E; Mostefa-Kara, A; Pagesy, P; Tachet, C | 1 |
| Kiyohara, T; Tanimura, H | 1 |
| Muchmore, DB; Vaughn, DE | 1 |
| Hompesch, M; Ludington, E; Morrow, L; Muchmore, DB; Vaughn, DE | 1 |
| Ikegami-Kawai, M; Inada, N; Nemoto, T; Okuda, R; Takahashi, T | 1 |
| Abboud, H; Arya, R; Blangero, J; Duggirala, R; Dyer, TD; Freeman, AB; Fu, DJ; Göring, HH; Hamlington, J; Hunt, KJ; Johnson-Pais, T; Konrad, RJ; Leach, RJ; Lehman, DM; Stern, MP | 1 |
| de Smet, MD; Grillone, LR; Kuppermann, BD; Thomas, EL | 1 |
| Hanover, JA; Love, DC | 1 |
| Fujii, S; Marutsuka, K; Sakamoto, T; Sobel, BE; Woodcock-Mitchell, J | 1 |
| Basuyau, JP; Chajara, A; Delpech, B; Leroy, M; Levesque, H; Raoudi, M | 1 |
3 review(s) available for hyaluronoglucosaminidase and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
Topics: Acetylglucosamine; Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antigens, Neoplasm; Brain; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Glycosylation; Hexosamines; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Insulin Resistance; Molecular Structure; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Phosphorylation; Protein Isoforms; Protein Processing, Post-Translational; Stroke; tau Proteins; Uridine Diphosphate; Uridine Diphosphate N-Acetylgalactosamine | 2020 |
Review of the mechanism of action and clinical efficacy of recombinant human hyaluronidase coadministration with current prandial insulin formulations.
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eating; Genetic Engineering; Glucose Clamp Technique; Humans; Hyaluronoglucosaminidase; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin Lispro; Intestinal Absorption; Recombinant Proteins | 2010 |
The hexosamine signaling pathway: deciphering the "O-GlcNAc code".
Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; Antigens, Neoplasm; beta-N-Acetylhexosaminidases; Caenorhabditis elegans Proteins; Computational Biology; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Hexosamines; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Mammals; Mice; Mice, Transgenic; Multienzyme Complexes; N-Acetylglucosaminyltransferases; Neoplasm Proteins; Neurodegenerative Diseases; Plant Proteins; Protein Processing, Post-Translational; Signal Transduction; Stress, Physiological; Uridine Diphosphate N-Acetylglucosamine | 2005 |
3 trial(s) available for hyaluronoglucosaminidase and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Increased OGA Expression and Activity in Leukocytes from Patients with Diabetes: Correlation with Inflammation Markers.
Topics: Adult; Antigens, Neoplasm; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Gene Expression Regulation, Enzymologic; Glycated Hemoglobin; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Leukocytes; Male; Middle Aged; RNA, Messenger | 2019 |
Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase.
Topics: Adolescent; Adult; Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hyaluronoglucosaminidase; Hypoglycemic Agents; Injections, Subcutaneous; Insulin Lispro; Insulin, Regular, Human; Male; Middle Aged; Postprandial Period; Treatment Outcome; United States; Young Adult | 2012 |
Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.
Topics: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hyaluronoglucosaminidase; Injections; Male; Middle Aged; Prospective Studies; Treatment Outcome; Visual Acuity; Vitreous Body; Vitreous Hemorrhage | 2005 |
7 other study(ies) available for hyaluronoglucosaminidase and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Haskap Berry Leaves (
Topics: alpha-Glucosidases; Antioxidants; Caffeic Acids; Carotenoids; Chlorogenic Acid; Diabetes Mellitus, Type 2; Fruit; Hyaluronoglucosaminidase; Lipase; Lonicera; Plant Leaves; Polyphenols; Rutin | 2022 |
Overexpression of p53 due to excess protein O-GlcNAcylation is associated with coronary microvascular disease in type 2 diabetes.
Topics: Animals; Apoptosis; Blood Glucose; Cells, Cultured; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelial Cells; Humans; Hyaluronoglucosaminidase; Male; Mice, Inbred C57BL; Mice, Transgenic; Microcirculation; Protein Processing, Post-Translational; Signal Transduction; Tumor Suppressor Protein p53; Up-Regulation | 2020 |
Diabetic scleroedema successfully treated by topical hyaluronidase injection: efficacy of magnetic resonance imaging.
Topics: Dermatologic Agents; Diabetes Mellitus, Type 2; Female; Humans; Hyaluronoglucosaminidase; Injections, Subcutaneous; Magnetic Resonance Imaging; Middle Aged; Scleroderma, Diffuse; Skin | 2019 |
Enhanced activity of serum and urinary hyaluronidases in streptozotocin-induced diabetic Wistar and GK rats.
Topics: Animals; Biomarkers; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Models, Animal; Hyaluronoglucosaminidase; Male; Rats; Rats, Wistar; Reference Values; Time Factors | 2004 |
A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans.
Topics: Acetylglucosaminidase; Acetyltransferases; Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Antigens, Neoplasm; beta-N-Acetylhexosaminidases; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Genotype; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Male; Mexican Americans; Middle Aged; Multienzyme Complexes; Neoplasm Proteins; Phenotype; Polymorphism, Single Nucleotide | 2005 |
Pathogenetic implications of hyaluronan-induced modification of vascular smooth muscle cell fibrinolysis in diabetes.
Topics: Antibodies; Aorta; Blotting, Western; Cells, Cultured; Culture Media, Conditioned; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fibrinolysis; Humans; Hyaluronan Receptors; Hyaluronic Acid; Hyaluronoglucosaminidase; L-Lactate Dehydrogenase; Muscle, Smooth, Vascular; Plasminogen Activator Inhibitor 1; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 1998 |
Increased hyaluronan and hyaluronidase production and hyaluronan degradation in injured aorta of insulin-resistant rats.
Topics: Animals; Aorta, Thoracic; Catheterization; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fructose; Hyaluronic Acid; Hyaluronoglucosaminidase; Hyperinsulinism; Hypertriglyceridemia; Insulin Resistance; Male; Molecular Weight; Organ Size; Rats; Rats, Wistar | 2000 |